Please login to read the full article.
Scrip Regulatory Affairs
Impact of the Paediatric Regulation on EU marketing authorisation holders: an EFPIA survey
02 June 2011
Angelika Joos, Judith Creba, Craig Johnson
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU industry cautious about proposed penalties under pharmacovigilance and paediatric frameworks
- US FDA issues much-awaited draft guidelines on developing biosimilars
- EU legislative proposal on clinical trials reforms likely in 2012
- US FDA consults on new approaches to facilitate medical device trials
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
